History

2024

Expanded indications, product line expanded to 4 models

2022

Localization completed, passed type testing, initiated NMPA registration

2020

Company merger and restructuring, established in China, R&D and production transferred to China

2016

Obtained FDA and CE Class I medical device registration certificates

2012

Obtained FDA and CE Class I medical device registration certificates

Contact Us
X
Name
Tel
Age
Disease Type
Email
City,State,and Zip Code
Intention Consultation Products
Self-Introduction